CELUW (Celularity) OCF Yield %: -29.73 (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CELUW Celularity Inc CELUW
38 GF Score
Price $0.01
! 6 Warning Signs
View Full Analysis

What is Celularity OCF Yield %?

Celularity CELUW 38 OCF Yield % is -29.73 as of Sep. 09, 2026. GuruFocus rates CELUW with a GF Score™ of 38/100. The stock has 6 warning signs investors should review. Among 1,407 Biotechnology companies, Celularity ranks worse than 75.98% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Celularity's Trailing 12-Month Cash Flow from Operations is $-13.25 Mil, and Market Cap is $0.00 Mil. Therefore, Celularity's OCF Yield % for today is -29.73%.

The historical rank and industry rank for Celularity's OCF Yield % or its related term are showing as below:

CELUW' s OCF Yield % Range Over the Past 10 Years
Min: -237.99   Med: -31.88   Max: -2.69
Current: -29.73


During the past 6 years, the highest OCF Yield % of Celularity was -2.69%. The lowest was -237.99%. And the median was -31.88%.

CELUW's OCF Yield % is ranked worse than
75.98% of 1407 companies
in the Biotechnology industry
Industry Median: -8.25 vs CELUW: -29.73

Celularity's OCF Margin % for the quarter that ended in Dec. 2025 was %.


Celularity OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Celularity OCF Yield % Related Terms


Celularity OCF Yield % Historical Data

* Premium members only.

The historical data trend for Celularity's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celularity OCF Yield % Chart

Celularity Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Celularity Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CELUW vs HOWL, MGX, TVGN: OCF Yield % Comparison

For the Biotechnology subindustry, Celularity's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Celularity OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celularity's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Celularity's OCF Yield % falls into.


CELUW
38GF Score
Celularity Inc CELUW
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Celularity OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Celularity's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-13.254 /
=N/A%

Celularity's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-5.103 * 4 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -29.73 mean?
Celularity (CELUW) has a OCF Yield % of -29.73 as of Sep. 09, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Celularity and its competitors. According to the industry distribution chart, Celularity ranks #1069 out of 1407 companies in the Biotechnology industry, placing it in the top 76%.
Is Celularity's OCF Yield % too high?
Celularity's current OCF Yield % is -29.73. Based on the distribution chart, Celularity ranks #1069 out of 1407 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Celularity has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Celularity's OCF Yield % compare to HOWL and MGX?
According to the Biotechnology industry distribution chart, Celularity ranks #1069 out of 1407 companies for OCF Yield %. This places Celularity in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Celularity and its competitors. Celularity's current OCF Yield % is -29.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Celularity stock overvalued right now?
Celularity (CELUW) has a current OCF Yield % of -29.73. The current OCF Yield % is -29.73. Celularity's overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Celularity (CELUW), the current OCF Yield % is -29.73 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Celularity Business Description

Other Exchanges CELU:USA
Address 170 Park Avenue, Florham Park, NJ, USA, 07932
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
38GF Score

Get the complete analysis for CELUW

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price